Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis
Cheryl S. Pirozzi,
Daniel L. Mendoza,
Yizhe Xu,
Yue Zhang,
Mary Beth Scholand and
Robert P. Baughman
Additional contact information
Cheryl S. Pirozzi: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
Daniel L. Mendoza: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
Yizhe Xu: Department of Population Health Science, University of Utah, Salt Lake City, UT 84132, USA
Yue Zhang: Divisions of Epidemiology and Public Health, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
Mary Beth Scholand: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
Robert P. Baughman: Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45219, USA
IJERPH, 2018, vol. 15, issue 6, 1-10
Abstract:
This study aimed to determine if short-term exposure to particulate matter (PM 2.5 ) and ozone (O 3 ) is associated with increased symptoms or lung function decline in fibrotic sarcoidosis. Sixteen patients with fibrotic sarcoidosis complicated by frequent exacerbations completed pulmonary function testing and questionnaires every three months for one year. We compared 7-, 10-, and 14-day average levels of PM 2.5 and O 3 estimated at patient residences to spirometry (forced expiratory volume in 1 s (FEV1), to forced vital capacity (FVC), episodes of FEV1 decline > 10%) and questionnaire outcomes (Leicester cough questionnaire (LCQ), Saint George Respiratory Questionnaire (SGRQ), and King’s Sarcoidosis Questionnaire (KSQ)) using generalized linear mixed effect models. PM 2.5 level averaged over 14 days was associated with lower KSQ general health status (score change −6.60 per interquartile range (IQR) PM 2.5 increase). PM 2.5 level averaged over 10 and 14 days was associated with lower KSQ lung specific health status (score change −6.93 and −6.91, respectively). PM 2.5 levels were not associated with FEV 1 , FVC, episodes of FEV 1 decline > 10%, or respiratory symptoms measured by SGRQ or LCQ. Ozone exposure was not associated with any health outcomes. In this small cohort of patients with fibrotic sarcoidosis, PM 2.5 exposure was associated with increased severity of respiratory and quality of life symptoms.
Keywords: sarcoidosis; air pollution; particulate matter; ozone; signs and symptoms; respiratory; pulmonary function tests (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.mdpi.com/1660-4601/15/6/1077/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/6/1077/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:6:p:1077-:d:149110
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().